Academia Employers Health System Payers Providers

Center on Health Equity and Access Clinical Health Care Cost Health Care Delivery Insurance Policy Technology Value-Based Care

All Coverage Event Coverage Interviews News

AJMC Journals Anniversary Author Forms Authors Nominate a Rising Leader Submit a Manuscript

Updates in the Treatment of Chronic Lymphocytic Leukemia: Implications for Managed Care

home / insights / updates-in-the-treatment-of-chronic-lymphocytic-leukemia

Pathophysiology and Treatment Landscape of CLL

EP. 1: Pathophysiology and Treatment Landscape of CLL

Watch

Increased Use of Targeted Therapies in CLL

EP. 2: Increased Use of Targeted Therapies in CLL

Watch

Health Plans Encourage Use of Diagnostic Tests in CLL

EP. 3: Health Plans Encourage Use of Diagnostic Tests in CLL

Watch

Impact of Major Trials on CLL Treatment

EP. 4: Impact of Major Trials on CLL Treatment

Watch

Pathophysiology, Prognostic Factors, and Potential Risks That Influence Treatment in CLL

EP. 5: Pathophysiology, Prognostic Factors, and Potential Risks That Influence Treatment in CLL

Watch

Flexibility in Treatment Options for CLL

EP. 6: Flexibility in Treatment Options for CLL

Watch

Combination Treatments in CLL

EP. 7: Combination Treatments in CLL

Watch

Factors That Influence Up-front Therapy and Sequencing in CLL

EP. 8: Factors That Influence Up-front Therapy and Sequencing in CLL

Watch

Impact of Novel Agents on Coverage Decisions in CLL

EP. 9: Impact of Novel Agents on Coverage Decisions in CLL

Watch

Efficacy and Safety Considerations to Improve the Value of Treatment in CLL

EP. 10: Efficacy and Safety Considerations to Improve the Value of Treatment in CLL

Watch

RESONATE-2 Trial: Safety and Efficacy Updates

EP. 11: RESONATE-2 Trial: Safety and Efficacy Updates

Watch

Patient Selection for Treatment With Ibrutinib in CLL

EP. 12: Patient Selection for Treatment With Ibrutinib in CLL

Watch

Treatment Options for Older Patients With CLL

EP. 13: Treatment Options for Older Patients With CLL

Watch

Expanding Options in Treating CLL

EP. 14: Expanding Options in Treating CLL

Watch

How Do Payers Assess Value of Treatments in CLL?

EP. 15: How Do Payers Assess Value of Treatments in CLL?

Watch

The Changing Treatment Paradigm in CLL

EP. 16: The Changing Treatment Paradigm in CLL

Watch

Safety of CLL Treatment and Reimbursement

EP. 17: Safety of CLL Treatment and Reimbursement

Watch

Safety and Efficacy Considerations in CLL

EP. 18: Safety and Efficacy Considerations in CLL

Watch

Looking to the Future in CLL Treatments

EP. 19: Looking to the Future in CLL Treatments

Watch

Value of Real-World Data in CLL Treatment

EP. 20: Value of Real-World Data in CLL Treatment

Watch

Outcomes From the RESONATE 2 and HELIOS Trials - Clinical Impact

EP. 21: Outcomes From the RESONATE 2 and HELIOS Trials - Clinical Impact

Watch

Unmet Needs and the Increased Use of Targeted Therapy in CLL

EP. 22: Unmet Needs and the Increased Use of Targeted Therapy in CLL

Watch

Diagnostic Testing and Evidence-Based Treatment in Cancer Care

EP. 23: Diagnostic Testing and Evidence-Based Treatment in Cancer Care

Watch

Influence of Treatment Modality on Outcomes in CLL

EP. 24: Influence of Treatment Modality on Outcomes in CLL

Watch

Weighing the Value of Treatments in CLL

EP. 25: Weighing the Value of Treatments in CLL

Watch

Editorial Staff

Editorial Boards

Do Not Sell My Information

Terms & Conditions

Contact Info

2 Clarke Drive
Cranbury, NJ 08512

© 2023 MJH Life Sciences
AJMC®
All rights reserved.